Clinical Trials on Recurrent Skin Cancer in Japan
Total 2126 results
-
Eisai Co., Ltd.Active, not recruiting
-
Translational Research Center for Medical Innovation...Department of breast and endocrine surgery graduate school of Medicine Osaka...Terminated
-
Kyowa Kirin Co., Ltd.Completed
-
Janssen Pharmaceutical K.K.CompletedMycoses | Candidiasis | Neutropenia | Aspergillosis | Cryptococcosis | Histoplasmosis | BlastomycosisJapan
-
TakedaCompletedPremenopausal Breast CancerJapan
-
Sakakibara Heart InstituteJapanese Foundation for Cancer ResearchCompletedCardiovascular Diseases | Cancer | PathogenesisJapan
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Federal University of São PauloEmory University; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University... and other collaboratorsActive, not recruitingBreast CancerBrazil, Canada, Italy, Japan
-
GlaxoSmithKlineCompleted
-
Astellas Pharma IncCompleted
-
Kyushu UniversityRecruitingPediatric Solid Tumors | Refractory/Relapse NeuroblastomaJapan
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Cutera Inc.CompletedMelasma | LentiginesChina, Japan
-
Showa Inan General HospitalCompletedColorectal Cancer ScreeningJapan
-
Takayuki YoshinoSumitomo Pharma Co., Ltd.Terminated
-
Kobe UniversityCompletedCoronary Artery Disease ProgressionJapan
-
Japan Blood Products OrganizationCompletedDermatomyositis | PolymyositisJapan
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
Zimmer BiometCompleted
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Kochi UniversityRecruitingPancreatic AdenocarcinomaJapan
-
Kyowa Kirin Co., Ltd.Active, not recruiting
-
Japan Society of Laparoscopic Colorectal SurgeryUnknown
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
GlaxoSmithKlineRecruiting
-
TakedaRecruitingHereditary Angioedema (HAE)Japan
-
AstraZenecaCompletedMetastatic Colorectal CancerJapan
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Bristol-Myers SquibbOno Pharma USA IncCompletedKidney Cancer | Renal CancerJapan
-
Chiba UniversityCompletedPancreatic Cancer | Bile Duct CancerJapan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Chugai PharmaceuticalUnknownMetastatic Colorectal CancerJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Nihon UniversityMebix IncUnknownDeep Vein Thrombosis | Pulmonary EmbolismJapan
-
AstraZenecaWithdrawnCancer | Non Small Cell Lung Cancer | Epithelial Ovarian CancerJapan
-
Maruho Co., Ltd.Completed
-
RS MedicalAccelerated Care Plus; Research Institute of Health and Science (RIHSE)Completed
-
University of YamanashiUnknown
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
AbbottEisai LimitedCompleted
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Kansai Hepatobiliary Oncology GroupCompletedBiliary Tract CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Kansai Hepatobiliary Oncology GroupCompletedBiliary Tract CancerJapan
-
GlaxoSmithKlineCompleted